tiprankstipranks
NRX Pharmaceuticals (NRXP)
NASDAQ:NRXP
US Market

NRX Pharmaceuticals (NRXP) Income Statement

Compare
434 Followers

NRX Pharmaceuticals Income Statement

Last quarter (Q3 2024), NRX Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, NRX Pharmaceuticals's net income was $-1.62M. See NRX Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -5.00K$ -4.00K$ -2.00K$ -907.41K
Operating Expenses
$ 19.70M$ 27.58M$ 44.40M$ 94.43M$ 11.90M
Depreciation and Amortization
$ 0.00$ 5.00K$ 4.00K$ 2.00K$ 2.00K
EBITDA
$ -18.50M$ -30.02M$ -39.75M$ -93.04M$ -51.72M
Operating Income
$ -18.50M$ -27.59M$ -44.40M$ -115.80M$ -51.39M
Other Income/Expenses
$ -6.62M$ -2.57M$ 4.58M$ 22.73M$ -39.88M
Pretax Income
$ -25.13M$ -30.16M$ -39.82M$ -93.06M$ -51.78M
Net Income
$ -25.13M$ -30.15M$ -35.23M$ -71.72M$ -12.35M
Per Share Metrics
Basic EPS
$ -2.39$ -3.98$ -0.54$ -1.53$ -0.36
Diluted EPS
$ -2.39$ -3.98$ -0.54$ -1.53$ -0.36
Weighted Average Shares Outstanding
10.52M 7.58M 65.77M 46.92M 34.27M
Weighted Average Shares Outstanding (Diluted)
10.52M 7.58M 65.77M 46.92M 34.27M
Currency in USD

NRX Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis